XML 60 R49.htm IDEA: XBRL DOCUMENT v3.24.2
Fair Value of Financial Instruments - Schedule of Quantitative Information and Assumptions Pertaining to the Fair Value Measurement of the Level 3 Inputs (Details)
$ in Thousands
Jun. 30, 2024
USD ($)
Dec. 31, 2023
USD ($)
Fair Value, Option, Quantitative Disclosures [Line Items]    
Contingent consideration liabilities $ 2,800 $ 2,700
Level 3    
Fair Value, Option, Quantitative Disclosures [Line Items]    
Contingent consideration liabilities 2,800 2,700
Level 3 | 1095 commercialization milestone    
Fair Value, Option, Quantitative Disclosures [Line Items]    
Contingent consideration liabilities 1,800 1,800
Level 3 | Net sales targets - AZEDRA and 1095    
Fair Value, Option, Quantitative Disclosures [Line Items]    
Contingent consideration liabilities $ 1,000 $ 900
Level 3 | Probability adjusted discounted cash flow model | Probability of success | 1095 commercialization milestone    
Fair Value, Option, Quantitative Disclosures [Line Items]    
Liability measurement input, percentage 0.40 0.40
Level 3 | Probability adjusted discounted cash flow model | Discount rate | 1095 commercialization milestone    
Fair Value, Option, Quantitative Disclosures [Line Items]    
Liability measurement input, percentage 0.045 0.041
Level 3 | Monte Carlo simulation | Probability of success | Net sales targets - AZEDRA and 1095 | Minimum    
Fair Value, Option, Quantitative Disclosures [Line Items]    
Liability measurement input, percentage 0 0
Level 3 | Monte Carlo simulation | Probability of success | Net sales targets - AZEDRA and 1095 | Maximum    
Fair Value, Option, Quantitative Disclosures [Line Items]    
Liability measurement input, percentage 0.40 0.40
Level 3 | Monte Carlo simulation | Discount rate | Net sales targets - AZEDRA and 1095    
Fair Value, Option, Quantitative Disclosures [Line Items]    
Liability measurement input, percentage 0.15 0.15